Publications 2016

Amorim S, Stathis A, Gleeson M, Iyengar S, Magarotto V, Leleu X, Morschhauser F, Karlin L, Broussais F, Rezai K, Herait P, Kahatt C, Lokiec F, Salles G, Facon T, Palumbo A, Cunningham D, Zucca E, Thieblemont C, 2016. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. Lancet Haematol. 3, E196–E204. doi:10.1016/S2352-3026(16)00021-1

Beauval N, Howsam M, Antherieu S, Allorge D, Soyez M, Garçon G, Goossens JF, Lo-Guidice JM, Garat A, 2016. Trace elements in e-liquids - Development and validation of an ICP-MS method for the analysis of electronic cigarette refills. Regul. Toxicol. Pharmacol. 79, 144–148. doi:10.1016/j.yrtph.2016.03.024

Belaiche S, Mercier E, Cuny D, Kambia N, Wierre P, Bertoux É, Mascaut D, Azar R, Bataille P, Bourdon F, Mac Namara É, Maisonneuve N, Painchart B, Vrigneau L, Noël C, Décaudin B, Glowacki F, 2016. [Community pharmacists’ interventions to prevent and screen chronic kidney disease patients]. Nephrol. Ther. doi:10.1016/j.nephro.2016.06.006

Billon L, Decaudin B, Lannoy D, Cuaz-Perolin C, Neuville S, Odou P, 2016. Assessment of the usability of parenteral nutrition bags. Nutr. Clin. Metab. 30, 179–188. doi:10.1016/j.nupar.2016.04.006

Bourdon F, Lecoeur M, Leconte L, Ultré V, Kouach M, Odou P, Vaccher C, Foulon C, 2016. Evaluation of Pentravan(®), Pentravan(®) Plus, Phytobase(®), Lipovan(®) and Pluronic Lecithin Organogel for the transdermal administration of antiemetic drugs to treat chemotherapy-induced nausea and vomiting at the hospital. Int J Pharm. doi:10.1016/j.ijpharm.2016.11.014

Brackman G, Garcia-Fernandez MJ, Lenoir J, De Meyer L, Remon JP, De Beer T, Concheiro A, Alvarez-Lorenzo C, Coenye T, 2016. Dressings Loaded with Cyclodextrin-Hamamelitannin Complexes Increase Staphylococcus aureus Susceptibility Toward Antibiotics Both in Single as well as in Mixed Biofilm Communities. Macromol. Biosci. 16, 859–869. doi:10.1002/mabi.201500437

Carde P, Karrasch M, Fortpied C, Brice P, Khaled H, Casasnovas O, Caillot D, Gaillard I, Bologna S, Ferme C, Lugtenburg PJ, Morschhauser F, Aurer I, Coiffier B, Meyer R, Seftel M, Wolf M, Glimelius B, Sureda A, Mounier N, 2016. Eight Cycles of ABVD Versus Four Cycles of BEACOPP(escalated) Plus Four Cycles of BEACOPP(baseline) in Stage III to IV, International Prognostic Score >= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial. J. Clin. Oncol. 34, 2028–+. doi:10.1200/JCO.2015.64.5648

Caron J, Chataigne G, Gimeno JP, Duhal N, Goossens JF, Dhulster P, Cudennec B, Ravallec R, Flahaut C, 2016a. Food peptidomics of in vitro gastrointestinal digestions of partially purified bovine hemoglobin: low-resolution versus high-resolution LC-MS/MS analyses. Electrophoresis 37, 1814–1822. doi:10.1002/elps.201500559

Caron J, Cudennec B, Domenger D, Belguesmia Y, Flahaut C, Kouach M, Lesage J, Goossens JF, Dhulster P, Ravallec R, 2016b. Simulated GI digestion of dietary protein: Release of new bioactive peptides involved in gut hormone secretion. Food Res. Int. 89, 382–390. doi:10.1016/j.foodres.2016.08.033

Caron J, Domenger D, Belguesmia Y, Kouach M, Lesage J, Goossens JF, Dhulster P, Ravallec R, Cudennec B, 2016c. Protein digestion and energy homeostasis: How generated peptides may impact intestinal hormones? Food Res. Int. 88, 310–318. doi:10.1016/j.foodres.2015.12.018

Cartron G, Hourcade-Potelleret F, Morschhauser F, Salles G, Wenger M, Truppel-Hartmann A, Carlile DJ, 2016. Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma. Haematologica 101, 226–234. doi:10.3324/haematol.2015.133421

Chamoun K, Choquet S, Boyle E, Houillier C, Larrieu-Ciron D, Al Jijakli A, Delrieu V, Delwail V, Morschhauser F, Hoang-Xuan K, Soussain C, 2016. Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series. Neurology. doi:10.1212/WNL.0000000000003420

Coiffier B, Thieblemont C, de Guibert S, Dupuis J, Ribrag V, Bouabdallah R, Morschhauser F, Navarro R, Le Gouill S, Haioun C, Houot R, Casasnovas O, Holte H, Lamy T, Broussais F, Payrard S, Hatteville L, Tilly H, 2016. A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. Br. J. Haematol. 173, 722–730. doi:10.1111/bjh.13992

Collet G, Breviere Y, Baillet C, Devos L, Vermandel M, Huglo D, 2016. Impact of a respiratory-gated (18)FDG PET-CT acquisition for the liver lesions diagnosis. Med. Nucl.-Imag. Fonct. Metab. 40, 84–91. doi:10.1016/j.mednuc.2015.12.001

Danel C, Melnyk P, Azaroual N, Larchanché PE, Goossens JF, Vaccher C, 2016. Evaluation of of three neutral capillary coatings for the determination of analyte-cyclodextrin binding constants by affinity capillary electrophoresis. Application to N,N ’-disubstituted piperazine derivatives. J. Chromatogr. A 1455, 163–171. doi:10.1016/j.chroma.2016.05.090

Diop M, Howsam M, Diop C, Cazier F, Goossens JF, Diouf A, Amara R, 2016a. Spatial and seasonal variations of trace elements concentrations in liver and muscle of round Sardinelle (Sardinella aurita) and Senegalese sole (Solea senegalensis) along the Senegalese coast. Chemosphere 144, 758–766. doi:10.1016/j.chemosphere.2015.08.085

Diop M, Howsam M, Diop C, Goossens JF, Diouf A, Amara R, 2016b. Assessment of trace element contamination and bioaccumulation in algae (Ulva lactuca), mussels (Perna perna), shrimp (Penaeus kerathurus), and fish (Mugil cephalus, Saratherondon melanotheron) along the Senegalese coast. Mar. Pollut. Bull. 103, 339–343. doi:10.1016/j.marpolbul.2015.12.038

Driowya M, Leclercq J, Verones V, Barczyk A, Lecoeur M, Renault N, Flouquet N, Ghinet A, Berthelot P, Lebegue N, 2016. Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agents. Eur. J. Med. Chem. 115, 393–405. doi:10.1016/j.ejmech.2016.03.056

Feutry F, Simon N, Genay S, Lannoy D, Barthelemy C, Decaudin B, Labalette P, Odou P, 2016. Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method. Drug Dev. Ind. Pharm. 42, 166–174. doi:10.3109/03639045.2015.1038273

Foinard A, Perez M, Barthélémy C, Lannoy D, Flamein F, Storme L, Addad A, Bout MA, Décaudin B, Odou P, 2016. In Vitro Assessment of Interaction Between Amino Acids and Copper in Neonatal Parenteral Nutrition. J. Parenter. Enter. Nutr. 40, 827–834. doi:10.1177/0148607115571967

Garcia-Fernandez MJ, Tabary N, Chai F, Cazaux F, Blanchemain N, Flament MP, Martel B, 2016. New multifunctional pharmaceutical excipient in tablet formulation based on citric acid-cyclodextrin polymer. Int. J. Pharm. 511, 913–920. doi:10.1016/j.ijpharm.2016.07.059

Herbaux C, Bertrand E, Marot G, Roumier C, Poret N, Soenen V, Nibourel O, Roche-Lestienne C, Broucqsault N, Galiègue-Zouitina S, Boyle EM, Fouquet G, Renneville A, Tricot S, Morschhauser F, Preudhomme C, Quesnel B, Poulain S, Leleu X, 2016. BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia. Oncotarget. doi:10.18632/oncotarget.9917

Houot R, Soussain C, Tilly H, Haioun C, Thieblemont C, Casasnovas O, Bouabdallah K, Morschhauser F, Le Gouill S, Salles GA, Hoang-Xuan K, Choquet S, Marchand T, Laurent C, Pangault C, Lamy T, 2016. Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA. Ann. Oncol. 27, 1349–1350. doi:10.1093/annonc/mdw138

Jaillard A, Baillet C, Béron A, Tabibzadeh N, Scherpereel A, Frimat M, Perbet R, Gnemmi V, Noël C, Huglo D, 2016. FDG PET/CT allowing detection and follow-up of tumor cell transplantation. Ann. Nucl. Med. 30, 250–254. doi:10.1007/s12149-015-1051-x

Kambia N, Farce A, Belarbi K, Gressier B, Luyckx M, Chavatte P, Dine T, 2016. Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate. J. Enzym. Inhib. Med. Chem. 31, 448–455. doi:10.3109/14756366.2015.1037748

Landagaray E, Vaccher C, Yous S, Lipka E, 2016. Design of experiments for enantiomeric separation in supercritical fluid chromatography. J. Pharm. Biomed. Anal. 120, 297–305. doi:10.1016/j.jpba.2015.12.041

Langner-Lemercier S, Houillier C, Soussain C, Ghesquières H, Chinot O, Taillandier L, Soubeyran P, Lamy T, Morschhauser F, Benouaich-Amiel A, Ahle G, Moles-Moreau MP, Moluçon-Chabrot C, Bourquard P, Damaj G, Jardin F, Larrieu D, Gyan E, Gressin R, Jaccard A, Choquet S, Brion A, Casasnovas O, Colin P, Reman O, Tempescul A, Marolleau JP, Fabbro M, Naudet F, Hoang-Xuan K, Houot R, 2016. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network. Neuro-Oncology 18, 1297–1303. doi:10.1093/neuonc/now033

Maiguy-Foinard A, Blanchemain N, Barthélémy C, Décaudin B, Odou P, 2016a. Influence of a Double-Lumen Extension Tube on Drug Delivery: Examples of Isosorbide Dinitrate and Diazepam. PLoS One 11. doi:10.1371/journal.pone.0154917

Maurer MJ, Jais JP, Ghesquieres H, Witzig TE, Hong FX, Haioun C, Thompson CA, Thieblemont C, Micallef IN, Porrata LF, Ribrag V, Nowakowski GS, Casasnovas O, Bologna S, Morschhauser F, Morrison VA, Peterson BA, Macon WR, Copie-Bergman C, Feldman AL, Syrbu SI, Kurtin PJ, Gascoyne RD, Li HL, Allmer C, Kahl BS, Ansell SM, Slager SL, Link BK, Salles G, Habermann TM, Tilly H, Cerhan JR, 2016. Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma. Am. J. Hematol. 91, 179–184. doi:10.1002/ajh.24223

Parent M, Boudier A, Maincent P, Gibot S, Ait-Oufella H, Boufenzer A, Jolly L, Derive M, Kouach M, Goossens JF, Leroy P, Clarot I, 2016. LR12-peptide quantitation in whole blood by RP-HPLC and intrinsic fluorescence detection: validation and pharmacokinetic study. Biomed. Chromatogr. doi:10.1002/bmc.3877

Patin F, Baranek T, Vourc’h P, Nadal-Desbarats L, Goossens JF, Marouillat S, Dessein AF, Descat A, Hounoum BM, Bruno C, Watier H, Si-Tahar M, Leman S, Lecron JC, Andres CR, Corcia P, Blasco H, 2016a. Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism. Neurotherapeutics 13, 905–917. doi:10.1007/s13311-016-0461-3

Patin F, Corcia P, Vourc’h P, Nadal-Desbarats L, Baranek T, Goossens JF, Marouillat S, Dessein AF, Descat A, Madji Hounoum B, Bruno C, Leman S, Andres CR, Blasco H, 2016b. Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism. Mol. Neurobiol. doi:10.1007/s12035-016-0078-x

Perrot A, Monjanel H, Bouabdallah R, Quittet P, Sarkozy C, Bernard M, Stamatoullas A, Borel C, Bouabdallah K, Nicolas-Virelizier E, Fournier M, Morschhauser F, Brice P, 2016. Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30(+) Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program. Haematologica 101, 466–473. doi:10.3324/haematol.2015.134213

Plaud B, Lefrant JY, 2016. The new Sfar journals are in place. Anaesth. Crit. Care Pain Med. 35, 1–2. doi:10.1016/j.accpm.2016.01.001

Pro B, Horwitz SM, Prince HM, Foss FM, Sokol L, Greenwood M, Caballero D, Morschhauser F, Wilhelm M, Iyer SP, Shustov AR, Wolfson J, Balser BE, Coiffier B, 2016. Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Hematol Oncol. doi:10.1002/hon.2320

Reboursiere E, Le Bras F, Herbaux C, Gyan E, Clavert A, Morschhauser F, Malak S, Sibon D, Broussais F, Braun T, Fornecker LM, Garidi R, Tricot S, Houot R, Joly B, Abarah W, Choufi B, Pham AD, Gac AC, Fruchart C, Marin E, Safar V, Parcelier A, Maisonneuve H, Bachy E, Cartron G, Jaccard A, Tournilhac O, Rossi C, Schirmer L, Martignoles JA, Gaulard P, Tilly H, Damaj G, Lymphoma Study Association Lysa Centers, 2016. Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Oncotarget. doi:10.18632/oncotarget.10764

Ribrag V, Koscielny S, Bosq J, Leguay T, Casasnovas O, Fornecker LM, Recher C, Ghesquieres H, Morschhauser F, Girault S, Gouill SL, Ojeda-Uribe M, Mariette C, Cornillon J, Cartron G, Verge V, Chassagne-Clément C, Dombret H, Coiffier B, Lamy T, Tilly H, Salles G, 2016. Rituximab and dose-dense chemotherapy for adults with Burkitt’s lymphoma: a randomised, controlled, open-label, phase 3 trial. Lancet 387, 2402–2411. doi:10.1016/S0140-6736(15)01317-3

Rogez-Florent T, Goossens L, Drucbert AS, Duban-Deweer S, Six P, Depreux P, Danzé PM, Goossens JF, Foulon C, 2016. Amine coupling versus biotin capture for the assessment of sulfonamide as ligands of hCA isoforms. Anal. Biochem. doi:10.1016/j.ab.2016.07.029

Schaefer A, Vermandel M, Baillet C, Dewalle-Vignion AS, Modzelewski R, Vera P, Massoptier L, Parcq C, Gibon D, Fechter T, Nemer U, Gardin I, Nestle U, 2016. Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation. Eur. J. Nucl. Med. Mol. Imaging 43, 911–924. doi:10.1007/s00259-015-3239-7

Segaoula Z, Leclercq J, Verones V, Flouquet N, Lecoeur M, Ach L, Renault N, Barczyk A, Melnyk P, Berthelot P, Thuru X, Lebegue N, 2016. Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity. J. Med. Chem. 59, 8422–8440. doi:10.1021/acs.jmedchem.6b00847

Shi Q, Flowers CR, Hiddemann W, Marcus R, Herold M, Hagenbeek A, Kimby E, Hochster H, Vitolo U, Peterson BA, Gyan E, Ghielmini M, Nielsen T, De Bedout S, Fu T, Valente N, Fowler NH, Hoster E, Ladetto M, Morschhauser F, Zucca E, Salles G, Sargent DJ, 2016. Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials. J. Clin. Oncol. JCO2016708651.

Sibon D, Morschhauser F, Resche-Rigon M, Ghez D, Dupuis J, Marçais A, Deau-Fischer B, Bouabdallah R, Sebban C, Salles G, Brice P, 2016. Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group. Haematologica 101, 474–481. doi:10.3324/haematol.2015.136408

Sidikou O, Simon N, Sergent G, Vasseur M, Pinturaud M, Richeval C, Allorge D, Decaudin B, Odou P, 2016. In Vitro Assessment of a New Extension Set Intended to Reduce Occupational Exposure to Antineoplastic Drugs During Hepatic Chemoembolisation. Cardiovasc. Interv. Radiol. 39, 141–143. doi:10.1007/s00270-015-1140-1

Simon N, Vasseur M, Chauffert B, Taillandier L, Le Rhun E, 2016a. Systemic therapies administration for adult patients in neuro-oncology: The standards of the Association of the neuro-oncologists of French expression (ANOCEF). Bull. Cancer 103, 400–401. doi:10.1016/j.bulcan.2016.01.011

Simon N, Vasseur M, Guillaussier A, Legrand JF, Lebecque M, Barthélémy C, Décaudin B, Odou P, 2016b. Potential Impact of Infusion Technique on Drug Delivery. Ther. Drug Monit. 38, 268–273.

Simon N, Vasseur M, Pinturaud M, Soichot M, Richeval C, Humbert L, Lebecque M, Sidikou O, Barthelemy C, Bonnabry P, Allorge D, Décaudin B, Odou P, 2016c. Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study. PLoS One 11. doi:10.1371/journal.pone.0159052

Spinelli V, Lalloyer F, Baud G, Osto E, Kouach M, Daoudi M, Vallez E, Raverdy V, Goossens JF, Descat A, Doytcheva P, Hubert T, Lutz TA, Lestavel S, Staels B, Pattou F, Tailleux A, 2016. Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. Int. J. Obes. 40, 1260–1267. doi:10.1038/ijo.2016.46

Tabary N, Garcia-Fernandez MJ, Danede F, Descamps M, Martel B, Willart JF, 2016. Determination of the glass transition temperature of cyclodextrin polymers. Carbohydr. Polym. 148, 172–180. doi:10.1016/j.carbpol.2016.04.032

Teodorescu F, Quéniat G, Foulon C, Lecoeur M, Barras A, Boulahneche S, Medjram MS, Hubert T, Abderrahmani A, Boukherroub R, Szunerits S, 2016. Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin. J Control Release 245, 137–146. doi:10.1016/j.jconrel.2016.11.029

Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S, 2016. Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial. J. Clin. Oncol. JCO2016693564.

Trněný M, Lamy T, Walewski J, Belada D, Mayer J, Radford J, Jurczak W, Morschhauser F, Alexeeva J, Rule S, Afanasyev B, Kaplanov K, Thyss A, Kuzmin A, Voloshin S, Kuliczkowski K, Giza A, Milpied N, Stelitano C, Marks R, Trümper L, Biyukov T, Patturajan M, Bravo ML, Arcaini L, 2016. Lenalidomide versus investigator’s choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial. Lancet Oncol. 17, 319–331. doi:10.1016/S1470-2045(15)00559-8

Truant S, Baillet C, Deshorgue AC, Leteurtre E, Hebbar M, Ernst O, Huglo D, Pruvot FR, 2016a. Drop of Total Liver Function in the Interstages of the New Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Technique: Analysis of the "Auxiliary Liver’’ by HIDA Scintigraphy. Ann. Surg. 263, e33–e34. doi:10.1097/SLA.0000000000001603

Truant S, Baillet C, Deshorgue AC, Leteurtre E, Hebbar M, Ernst O, Pruvot FR, 2016b. Hepatobiliary Scintigraphy in ALPPS: A Response. Ann. Surg. doi:10.1097/SLA.0000000000001941

von Tresckow B, Morschhauser F, Szer J, Eichenauer DA, Abramson JS, Sureda A, Engert A, 2016. Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation. Leuk. Lymphoma 1–4. doi:10.1080/10428194.2016.1182164

Walter HS, Rule SA, Dyer MJS, Karlin L, Jones C, Cazin B, Quittet P, Shah N, Hutchinson CV, Honda H, Duffy K, Birkett J, Jamieson V, Courtenay-Luck N, Yoshizawa T, Sharpe J, Ohno T, Abe S, Nishimura A, Cartron G, Morschhauser F, Fegan C, Salles G, 2016. A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies. Blood 127, 411–419. doi:10.1182/blood-2015-08-664086

Wambang N, Schifano-Faux N, Aillerie A, Baldeyrou B, Jacquet C, Bal-Mahieu C, Bousquet T, Pellegrini S, Ndifon PT, Meignan S, Goossens JF, Lansiaux A, Pélinski L, 2016a. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors. Bioorg. Med. Chem. 24, 651–660. doi:10.1016/j.bmc.2015.12.033

Wambang N, Schifano-Faux N, Martoriati A, Henry N, Baldeyrou B, Bal-Mahieu C, Bousquet T, Pellegrini S, Meignan S, Cailliau K, Goossens JF, Bodart JF, Ndifon PT, Pelinski L, 2016b. Synthesis, Structure, and Antiproliferative Activity of Ruthenium(II) Arene Complexes of Indenoisoquinoline Derivatives. Organometallics 35, 2868–2872. doi:10.1021/acs.organomet.6b00440

Wattier JM, Caïazzo R, Andrieu G, Kipnis E, Pattou F, Lebuffe G, 2016. Chronic post-thyroidectomy pain: Incidence, typology, and risk factors. Anaesth. Crit. Care Pain Med. 35, 197–201. doi:10.1016/j.accpm.2015.10.006

Younes A, Ansell S, Fowler N, Wilson W, de Vos S, Seymour J, Advani R, Forero A, Morschhauser F, Kersten MJ, Tobinai K, Zinzani PL, Zucca E, Abramson J, Vose J, 2016. The landscape of new drugs in lymphoma. Nat Rev Clin Oncol. doi:10.1038/nrclinonc.2016.205

Zinzani PL, Karlin L, Radford J, Caballero D, Fields P, Chamuleau ME, D’ Amore F, Haioun C, Thieblemont C, González-Barca E, Grande García C, Johnson PW, van Imhoff GW, Ng T, Dwyer K, Morschhauser F, 2016. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica. doi:10.3324/haematol.2016.146977